CELL THERAPIES FAILING
A number of pre-clinical and clinical studies have been or are being conducted on the delivery of cell-based therapies to treat heart failure (source: ClinicalTrials.gov). We believe that the reason for the failure of many of these studies to show therapeutic effectiveness is that the cells are not retained in or adjacent to the area of heart injury long enough to provide benefit. Improving therapeutic cell retention in the heart presents a significant opportunity for CL.
